Key facts

  • A world lead within diabetes and haemophilia
  • Sales totalled DKK 66.3 billion in 2011 (Eur 8.9 billion)
  • In 2011 total insulin market of 50% and modern insulin market share 46%, measured by volume (Source IMS)
  • Some 32.136 Full time employees
  • Focus on core areas with large unmet medical needs: Diabetes care, haemophilia, growth hormone disorders and other biopharmaceuticals
  • Strong global marketing network
  • Listed on NASDAQ OMX Copenhagen and New York Exchanges